These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1618253)

  • 21. Serum glycoside concentrations after single or repeated intravenous doses of beta-methyl-digoxin and digoxin.
    Marinow J; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1977 Mar; 11(3):213-8. PubMed ID: 856604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enantioselective disposition of salbutamol in man following oral and intravenous administration.
    Boulton DW; Fawcett JP
    Br J Clin Pharmacol; 1996 Jan; 41(1):35-40. PubMed ID: 8824691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intravenous magnesium infusion on salbutamol-induced bronchodilatation in patients with asthma.
    Rolla G; Bucca C; Brussino L; Colagrande P
    Magnes Res; 1994 Jun; 7(2):129-33. PubMed ID: 7999527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
    De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G
    Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.
    Hanratty CG; Silke B; Riddell JG
    Br J Clin Pharmacol; 1999 Feb; 47(2):157-66. PubMed ID: 10190650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential.
    Du Plooy WJ; Hay L; Kahler CP; Schutte PJ; Brandt HD
    Br J Pharmacol; 1994 Jan; 111(1):73-6. PubMed ID: 8012727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
    Crane J; Burgess C; Beasley R
    Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis.
    Demnati R; Michoud MC; Jeanneret-Grosjean A; Ong H; Du Souich P
    Br J Clin Pharmacol; 1995 Oct; 40(4):319-24. PubMed ID: 8554933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
    Silke B; Hanratty CG; Riddell JG
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment.
    Jogestrand T; Ericsson F; Sundqvist K
    Eur J Clin Pharmacol; 1981 Jan; 19(2):97-105. PubMed ID: 7202477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Eur J Clin Pharmacol; 1992; 42(5):481-5. PubMed ID: 1606994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle binding and renal excretion of digoxin in man.
    Schenck-Gustafsson K; Jogestrand T; Dahlqvist R
    Eur J Clin Pharmacol; 1987; 31(5):601-3. PubMed ID: 3830246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of oral salbutamol on cation transport measured in vivo in healthy volunteers.
    Wood AJ; Brearley CJ; Aronson JK; Grahame-Smith DG
    Br J Clin Pharmacol; 1990 Sep; 30(3):383-90. PubMed ID: 2171617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of beta 2-adrenoceptor stimulation on cardiac metabolism in the conscious dog.
    Shanahan EA; Wahlqvist ML; Wilmshurst EG
    Br J Pharmacol; 1979 Jun; 66(2):229-33. PubMed ID: 465875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic effects of salbutamol and salmeterol in patients with asthma.
    Bennett JA; Smyth ET; Pavord ID; Wilding PJ; Tattersfield AE
    Thorax; 1994 Aug; 49(8):771-4. PubMed ID: 8091321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salbutamol disposition and dynamics in conscious rabbits: influence of the route of administration and of the dose.
    Perreault S; Ong H; du Souich P
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):461-76. PubMed ID: 1287197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo effects of SCA40 on guinea pig airways.
    Buchheit KH; Hofmann A; Pfannkuche HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):217-23. PubMed ID: 9050015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
    Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
    Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of diprafenone on the pharmacokinetics of digoxin.
    Koytchev R; Alken RG; Mayer O
    Eur J Clin Pharmacol; 1996; 50(1-2):97-100. PubMed ID: 8739818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.